Literature DB >> 18411255

The S18Y polymorphic variant of UCH-L1 confers an antioxidant function to neuronal cells.

Elli Kyratzi1, Maria Pavlaki, Leonidas Stefanis.   

Abstract

A number of studies have associated the S18Y polymorphic variant of UCH-L1 with protection from sporadic Parkinson's Disease (PD). The mechanism involved in this protective function is unknown, but has generally been assumed to be linked to the ubiquitin-proteasome system (UPS). In the current study, we have investigated the effects of overexpression of UCH-L1 and its variants, including S18Y, in neuronal cells. We find that S18Y, but not WT, UCH-L1 confers a specific antioxidant protective function when expressed at physiological levels in human neuroblastoma cells and primary cortical neurons. In contrast, neither WT nor S18Y UCH-L1 appear to directly impact the proteasome, although they both lead to stabilization of free ubiquitin. Lack of WT mouse UCH-L1 in neurons derived from gad mice led to a decrease of free ubiquitin, but no overall decrease in UPS function or enhanced sensitivity to oxidative stress. We conclude that the S18Y variant of UCH-L1 confers a novel antioxidant function that is not present in the WT form and that this function may underlie the protective effects of this variant in certain PD populations. Our results furthermore provide indirect evidence for the importance of oxidative stress as a pathogenetic factor in certain forms of sporadic PD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18411255     DOI: 10.1093/hmg/ddn115

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  18 in total

1.  Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease.

Authors:  Zhihua Liu; Robin K Meray; Tom N Grammatopoulos; Ross A Fredenburg; Mark R Cookson; Yichin Liu; Todd Logan; Peter T Lansbury
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-04       Impact factor: 11.205

Review 2.  Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications.

Authors:  Qian Huang; Maria E Figueiredo-Pereira
Journal:  Apoptosis       Date:  2010-11       Impact factor: 4.677

3.  Genetic risk factors in Parkinson's disease: single gene effects and interactions of genotypes.

Authors:  Anna Göbel; Eric A Macklin; Susen Winkler; Rebecca A Betensky; Christine Klein; Katja Lohmann; David K Simon
Journal:  J Neurol       Date:  2012-08-10       Impact factor: 4.849

4.  Ubiquitin vinyl methyl ester binding orients the misaligned active site of the ubiquitin hydrolase UCHL1 into productive conformation.

Authors:  David A Boudreaux; Tushar K Maiti; Christopher W Davies; Chittaranjan Das
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

5.  The UCHL1 S18Y polymorphism and Parkinson's disease in a Japanese population.

Authors:  Katherine W Snapinn; Eric B Larson; Hideshi Kawakami; Hiroshi Ujike; Amy R Borenstein; Yuishin Izumi; Ryuji Kaji; Hirofumi Maruyama; Ignacio F Mata; Hiroyuki Morino; Masaya Oda; Debby W Tsuang; Dora Yearout; Karen L Edwards; Cyrus P Zabetian
Journal:  Parkinsonism Relat Disord       Date:  2011-02-22       Impact factor: 4.891

6.  Rare Disease Mechanisms Identified by Genealogical Proteomics of Copper Homeostasis Mutant Pedigrees.

Authors:  Stephanie A Zlatic; Alysia Vrailas-Mortimer; Avanti Gokhale; Lucas J Carey; Elizabeth Scott; Reid Burch; Morgan M McCall; Samantha Rudin-Rush; John Bowen Davis; Cortnie Hartwig; Erica Werner; Lian Li; Michael Petris; Victor Faundez
Journal:  Cell Syst       Date:  2018-01-31       Impact factor: 10.304

7.  Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer's disease.

Authors:  Madeleine Zetterberg; Annica Sjölander; Malin von Otter; Mona Seibt Palmér; Sara Landgren; Lennart Minthon; Anders Wallin; Niels Andreasen; Kaj Blennow; Henrik Zetterberg
Journal:  Mol Neurodegener       Date:  2010-03-19       Impact factor: 14.195

8.  Regulation of synaptic structure by ubiquitin C-terminal hydrolase L1.

Authors:  Anna E Cartier; Stevan N Djakovic; Afshin Salehi; Scott M Wilson; Eliezer Masliah; Gentry N Patrick
Journal:  J Neurosci       Date:  2009-06-17       Impact factor: 6.167

9.  Pesticides that inhibit the ubiquitin-proteasome system: effect measure modification by genetic variation in SKP1 in Parkinson׳s disease.

Authors:  Shannon L Rhodes; Arthur G Fitzmaurice; Myles Cockburn; Jeff M Bronstein; Janet S Sinsheimer; Beate Ritz
Journal:  Environ Res       Date:  2013-08-27       Impact factor: 6.498

10.  SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease.

Authors:  Rubén Fernández-Santiago; Núria Martín-Flores; Francesca Antonelli; Catalina Cerquera; Verónica Moreno; Sara Bandres-Ciga; Elisabetta Manduchi; Eduard Tolosa; Andrew B Singleton; Jason H Moore; María-Josep Martí; Mario Ezquerra; Cristina Malagelada
Journal:  Mov Disord       Date:  2019-06-24       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.